Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
about
Oncolytic viruses as immunotherapy: progress and remaining challengesStem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open QuestionsMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesSui generis: gene therapy and delivery systems for the treatment of glioblastomaCombinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.Neural stem cell therapy for cancer.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Current status of gene therapy for brain tumors.Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas.Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.Directing systemic oncolytic viral delivery to tumors via carrier cellsOncolytic adenoviruses: A thorny path to glioma cureNeural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant gliomaConvergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapiesGene therapy for malignant glioma.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.Frontiers in Suicide Gene Therapy of Cancer.Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells.The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastomaAdenoviral virotherapy for malignant brain tumorsStrategies in gene therapy for glioblastoma.Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapyStem cells as delivery vehicles for oncolytic adenoviral virotherapy.Applications of neural and mesenchymal stem cells in the treatment of gliomas.Viruses, gene therapy and stem cells for the treatment of human glioma.Crossing the boundaries: stem cells and gene therapy.Targeted therapy in the treatment of malignant gliomasRecent advances in oncolytic virus design.Neurotransplantation: lux et veritas, fiction or reality?The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates.Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.Therapeutic cell carriers: a potential road to cure glioma.
P2860
Q26745942-91A92A49-01F1-447B-A100-B5DC1AD40222Q26775038-74752F6B-CE6A-4F8C-B0E9-F7C77D85BBC1Q26799013-C56DCA7A-65B8-4B0A-AA06-70D81456B738Q26850467-A86A4343-36C8-479A-AA22-BC0D66A6A2A4Q33594142-B01D2F67-2AB2-44F9-8116-B59F4906C13AQ33704489-05C81D41-EFA0-402B-B449-E6ACD2A90433Q34102273-18768196-4903-42D5-BC53-2825A684C10DQ34217778-2219BB36-3F2B-40D6-A1F8-A490D753D25FQ34240433-A1912F69-B2B1-46B5-B876-54E18E4A2FC9Q34318157-398B6248-3EE5-4025-B27F-0B4E57629B7FQ34647951-3FDC6F34-C7E5-4A40-BB02-2401CC2022ACQ34943738-BBF6BF81-AD5C-4F1D-A508-1E13EFFEA8D4Q35029126-1DC6C2D2-90F6-4B70-88F0-395C1348B90EQ35077747-8934A041-CAAF-4BD6-81AD-49181A20AD28Q35238250-F7188EF4-6D2A-4DB0-9488-9678F5B65DFDQ35256949-782C055F-61A1-486D-A5BB-DB167253F324Q35331907-65D92C91-B32A-4A49-87FB-11B24466451DQ35673628-B98E309D-2FFA-4B92-94CF-1544251F03A7Q35795073-234EA9CF-51C0-46E0-9DF5-20873B43BE57Q35973436-3B593529-742C-4083-81EC-422D2790B3FDQ36083446-CC94825B-92CA-4C5D-9C8C-6F2380E7E376Q36534930-FA65C2E1-ABB3-495E-BB69-7A112B44551EQ36634430-7CB3A9A0-9472-4853-AA27-8612D2818810Q36976226-57AADC6E-2233-4DFB-81D6-6240186B8B9AQ37029367-5A75EBB1-8191-4187-8FD6-617FF4453587Q37109638-3E70C379-3312-4AE0-9662-B0B93C7234FFQ37124552-01C2E200-E635-484E-A15C-BAC1F2EC9589Q37223846-77046544-4FE8-4700-AF96-DC43FF999AB7Q37420576-FF9FA4D0-EB66-499C-A17E-6136FB92528FQ37427886-CB370273-C831-44E1-937C-B5AF702480D7Q37466041-B1660275-A656-44A0-80F1-50029D2942B6Q37483966-474A55FA-8E28-4C17-BF6D-2320A7A946C8Q37567452-CB2D6BDE-3BD8-4F59-AAB9-42F7F3804FD0Q37720803-A719260D-99C3-4A28-8459-2B2B3BD0370BQ37771247-C2E09AE1-BF5C-4128-98FA-3F3E756B8C05Q37865172-A7634EFE-BEFA-433F-9801-78365152E51EQ37971309-5BBB632D-AF4A-4B20-8D2B-83711C710A2FQ38044698-6B3B1D88-772C-4DE4-A524-5986D280E8C5Q38112074-B3A613B5-6C11-47E5-8FEA-4BBFEE4AD1A7Q38213836-EF7149CE-4786-40CD-A04F-14B9CB117CE6
P2860
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
@en
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
@nl
type
label
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
@en
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
@nl
prefLabel
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
@en
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
@en
P2093
A M Sonabend
M S Lesniak
P2860
P2888
P304
P356
10.1038/GT.2008.165
P50
P577
2008-12-11T00:00:00Z